A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 5
- Registration Number
- NCT04906980
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 260
- Registration Number
- NCT04898634
- Locations
- 🇨🇳
Sun Yat Sen University Cancer Center, Guang Zhou Shi, China
🇺🇸Columbia University Medical Center Herbert Irving Pavilion, New York, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
- Conditions
- Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
- Interventions
- Other: Placebo
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 17935
- Registration Number
- NCT04899336
- Locations
- 🇬🇧
Ashgrove Surgery, Pontypridd, United Kingdom
🇬🇧The Adam Practice, Poole, United Kingdom
🇮🇳Nil Ratan Sircar Medical College and Hospital, Kolkata, India
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 228
- Registration Number
- NCT04882878
- Locations
- 🇪🇸
Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain
🇺🇦Medbud-Clinic LLC, Kyiv, Ukraine
🇺🇸Valerius Medical Group & Research Center, Los Alamitos, California, United States
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
- Conditions
- Lupus Nephritis
- Interventions
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 80
- Registration Number
- NCT04883619
- Locations
- 🇺🇸
Omega Research Consultants, DeBary, Florida, United States
🇺🇸Valerius Medical Group & Research Center, Los Alamitos, California, United States
🇺🇸Respire Research, LLC, Palm Springs, California, United States
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
- Conditions
- Arthritis, Psoriatic
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 1054
- Registration Number
- NCT04882098
- Locations
- 🇭🇷
University Hospital Center Split, Split, Croatia
🇭🇷Klinicki bolnicki centar Zagreb, Zagreb, Croatia
🇭🇷Medicinski centar Kuna & Peric, Zagreb, Croatia
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
- Conditions
- Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin
- Interventions
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 45
- Registration Number
- NCT04876092
- Locations
- 🇫🇷
Institut Paoli Calmettes, Marseille, France
🇫🇷Hopital St Louis, Paris, France
🇩🇰Rigshospitalet, Copenhagen, Denmark
A Study of JNJ-56136379 in Healthy Participants
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT04853524
A Study of Nipocalimab in Healthy Male and Female Participants
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 89
- Registration Number
- NCT04848558
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
A Study of JNJ-68179280 in Healthy Participants
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 94
- Registration Number
- NCT04844463
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States